Cargando…

Synthea™ Novel coronavirus (COVID-19) model and synthetic data set

March through May 2020, a model of novel coronavirus (COVID-19) disease progression and treatment was constructed for the open-source Synthea patient simulation. The model was constructed using three peer-reviewed publications published in the early stages of the global pandemic, when less was known...

Descripción completa

Detalles Bibliográficos
Autores principales: Walonoski, Jason, Klaus, Sybil, Granger, Eldesia, Hall, Dylan, Gregorowicz, Andrew, Neyarapally, George, Watson, Abigail, Eastman, Jeff
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The MITRE Corporation. Published by Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531559/
https://www.ncbi.nlm.nih.gov/pubmed/33043312
http://dx.doi.org/10.1016/j.ibmed.2020.100007
_version_ 1783589780599078912
author Walonoski, Jason
Klaus, Sybil
Granger, Eldesia
Hall, Dylan
Gregorowicz, Andrew
Neyarapally, George
Watson, Abigail
Eastman, Jeff
author_facet Walonoski, Jason
Klaus, Sybil
Granger, Eldesia
Hall, Dylan
Gregorowicz, Andrew
Neyarapally, George
Watson, Abigail
Eastman, Jeff
author_sort Walonoski, Jason
collection PubMed
description March through May 2020, a model of novel coronavirus (COVID-19) disease progression and treatment was constructed for the open-source Synthea patient simulation. The model was constructed using three peer-reviewed publications published in the early stages of the global pandemic, when less was known, along with emerging resources, data, publications, and clinical knowledge. The simulation outputs synthetic Electronic Health Records (EHR), including the daily consumption of Personal Protective Equipment (PPE) and other medical devices and supplies. For this simulation, we generated 124,150 synthetic patients, with 88,166 infections and 18,177 hospitalized patients. Patient symptoms, disease severity, and morbidity outcomes were calibrated using clinical data from the peer-reviewed publications. 4.1% of all simulated infected patients died and 20.6% were hospitalized. At peak observation, 548 dialysis machines and 209 mechanical ventilators were needed. This simulation and the resulting data have been used for the development of algorithms and prototypes designed to address the current or future pandemics, and the model can continue to be refined to incorporate emerging COVID-19 knowledge, variations in patterns of care, and improvement in clinical outcomes. The resulting model, data, and analysis are available as open-source code on GitHub and an open-access data set is available for download.
format Online
Article
Text
id pubmed-7531559
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The MITRE Corporation. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-75315592020-10-05 Synthea™ Novel coronavirus (COVID-19) model and synthetic data set Walonoski, Jason Klaus, Sybil Granger, Eldesia Hall, Dylan Gregorowicz, Andrew Neyarapally, George Watson, Abigail Eastman, Jeff Intell Based Med Article March through May 2020, a model of novel coronavirus (COVID-19) disease progression and treatment was constructed for the open-source Synthea patient simulation. The model was constructed using three peer-reviewed publications published in the early stages of the global pandemic, when less was known, along with emerging resources, data, publications, and clinical knowledge. The simulation outputs synthetic Electronic Health Records (EHR), including the daily consumption of Personal Protective Equipment (PPE) and other medical devices and supplies. For this simulation, we generated 124,150 synthetic patients, with 88,166 infections and 18,177 hospitalized patients. Patient symptoms, disease severity, and morbidity outcomes were calibrated using clinical data from the peer-reviewed publications. 4.1% of all simulated infected patients died and 20.6% were hospitalized. At peak observation, 548 dialysis machines and 209 mechanical ventilators were needed. This simulation and the resulting data have been used for the development of algorithms and prototypes designed to address the current or future pandemics, and the model can continue to be refined to incorporate emerging COVID-19 knowledge, variations in patterns of care, and improvement in clinical outcomes. The resulting model, data, and analysis are available as open-source code on GitHub and an open-access data set is available for download. The MITRE Corporation. Published by Elsevier B.V. 2020-11 2020-10-02 /pmc/articles/PMC7531559/ /pubmed/33043312 http://dx.doi.org/10.1016/j.ibmed.2020.100007 Text en © 2020 The MITRE Corporation Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Walonoski, Jason
Klaus, Sybil
Granger, Eldesia
Hall, Dylan
Gregorowicz, Andrew
Neyarapally, George
Watson, Abigail
Eastman, Jeff
Synthea™ Novel coronavirus (COVID-19) model and synthetic data set
title Synthea™ Novel coronavirus (COVID-19) model and synthetic data set
title_full Synthea™ Novel coronavirus (COVID-19) model and synthetic data set
title_fullStr Synthea™ Novel coronavirus (COVID-19) model and synthetic data set
title_full_unstemmed Synthea™ Novel coronavirus (COVID-19) model and synthetic data set
title_short Synthea™ Novel coronavirus (COVID-19) model and synthetic data set
title_sort synthea™ novel coronavirus (covid-19) model and synthetic data set
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531559/
https://www.ncbi.nlm.nih.gov/pubmed/33043312
http://dx.doi.org/10.1016/j.ibmed.2020.100007
work_keys_str_mv AT walonoskijason syntheanovelcoronaviruscovid19modelandsyntheticdataset
AT klaussybil syntheanovelcoronaviruscovid19modelandsyntheticdataset
AT grangereldesia syntheanovelcoronaviruscovid19modelandsyntheticdataset
AT halldylan syntheanovelcoronaviruscovid19modelandsyntheticdataset
AT gregorowiczandrew syntheanovelcoronaviruscovid19modelandsyntheticdataset
AT neyarapallygeorge syntheanovelcoronaviruscovid19modelandsyntheticdataset
AT watsonabigail syntheanovelcoronaviruscovid19modelandsyntheticdataset
AT eastmanjeff syntheanovelcoronaviruscovid19modelandsyntheticdataset